학술논문
Sustained Response to Selinexor-Based Therapy for Triple-Class Refractory Multiple Myeloma with Early Relapse After Allogeneic Stem Cell Transplantation
Document Type
Article
Author
Source
In: Clinical Lymphoma, Myeloma and Leukemia . (Clinical Lymphoma, Myeloma and Leukemia, July 2021, 21(7):e630-e634)
Subject
Language
English
ISSN
21522669
21522650
21522650